Syndax Pharmaceuticals (SNDX) Leases (2019 - 2025)
Historic Leases for Syndax Pharmaceuticals (SNDX) over the last 7 years, with Q3 2025 value amounting to $1.5 million.
- Syndax Pharmaceuticals' Leases rose 9457.67% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 9457.67%. This contributed to the annual value of $2.0 million for FY2024, which is 3597.85% up from last year.
- Syndax Pharmaceuticals' Leases amounted to $1.5 million in Q3 2025, which was up 9457.67% from $1.6 million recorded in Q2 2025.
- In the past 5 years, Syndax Pharmaceuticals' Leases registered a high of $2.0 million during Q4 2024, and its lowest value of $338000.0 during Q2 2021.
- Moreover, its 5-year median value for Leases was $1.1 million (2021), whereas its average is $1.2 million.
- In the last 5 years, Syndax Pharmaceuticals' Leases skyrocketed by 23896.55% in 2021 and then tumbled by 5632.58% in 2024.
- Quarter analysis of 5 years shows Syndax Pharmaceuticals' Leases stood at $983000.0 in 2021, then increased by 5.7% to $1.0 million in 2022, then skyrocketed by 43.12% to $1.5 million in 2023, then surged by 35.98% to $2.0 million in 2024, then fell by 27.25% to $1.5 million in 2025.
- Its last three reported values are $1.5 million in Q3 2025, $1.6 million for Q2 2025, and $1.8 million during Q1 2025.